Finanzwire Finanzwire
Basculer en Français
10697 Companies
228540 Keywords
157116 Articles
121262 Press releases
Headlines Articles Press releases Belhaven Biopharma Remove
  1. Home
  2. Companies
  3. Belhaven Biopharma
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 07/09/2024 at 17:05, 1 year 11 months ago

    Belhaven Biopharma Study Shows Promising Results for Nasal Epinephrine Delivery

    Belhaven Biopharma Nasdepi Anaphylaxis Treatment Medical Research Nasal Epinephrine
  • PRESS RELEASE

    published on 07/09/2024 at 17:00, 1 year 11 months ago

    New Canine Study From Belhaven Biopharma Supports Dry Powder Nasal Epinephrine Delivery Solution

    Belhaven Biopharma presents promising results of Nasdepi Canine Study at Respiratory Drug Delivery 2024, indicating faster & effective treatment for anaphylaxis. Intranasal dry powder epinephrine offers breakthrough prospects in emergency care for severe allergies
    Belhaven Biopharma Anaphylaxis Treatment Nasdepi Canine Study Dry Powder Nasal Solution Respiratory Drug Delivery 2024
    Logo of Belhaven Biopharma
  • PRESS RELEASE

    published on 02/08/2024 at 18:30, 2 years 4 months ago

    Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product

    Belhaven Biopharma shares positive results from Phase 1 clinical trial of Nasdepi, a nasal dry powder epinephrine device for treating anaphylaxis. Successful investor round and Series A financing on the horizon
    Phase 1 Clinical Trial Series A Financing Belhaven Biopharma Nasdepi Anaphylaxis Treatment
    Logo of Belhaven Biopharma
  • PRESS RELEASE

    published on 11/28/2023 at 19:30, 2 years 7 months ago

    Belhaven Biopharma Achieves Significant Milestones in Advancing Nasdepi - a Revolutionary Nasal Dry Powder Epinephrine Product

    Logo of Belhaven Biopharma
Accesswire
  • Published on 07/08/2026 at 08:00, 51 minutes ago

    Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder

  • Published on 07/08/2026 at 03:25, 5 hours 26 minutes ago

    Linear Provides Update on Proposed Acquisition of Critical Prospecting Corp

  • Published on 07/08/2026 at 01:10, 7 hours 41 minutes ago

    Galantas Announces Resignation of Chair of the Board

  • Published on 07/07/2026 at 23:15, 9 hours 36 minutes ago

    Guanajuato Silver Announces Officer Resignation

  • Published on 07/07/2026 at 22:15, 10 hours 36 minutes ago

    Grande Portage Closes C$6 Million Equity Financing

View all ACCESSWIRE
EQS Group
  • Published on 07/08/2026 at 08:38, 12 minutes ago

    innoscripta SE Accelerates Regional Expansion with New Hamburg Office

  • Published on 07/08/2026 at 08:30, 21 minutes ago

    Energiekontor AG: Energiekontor successfully commissions sold Drensteinfurt-Rieth wind park and obtains further building permits

  • Published on 07/08/2026 at 08:00, 51 minutes ago

    Zentra Group plc: Loan Facility Extension

  • Published on 07/08/2026 at 08:00, 51 minutes ago

    naoo launches globally unique product format

  • Published on 07/08/2026 at 07:53, 58 minutes ago

    Einhell continues growth trajectory – strong signal at the 2026 Annual General Meeting

View all EQS
Les Echos
  • Published on 07/07/2026 at 19:53, 12 hours 58 minutes ago

    GROUPE SFPI: New Deputy Managing Director

  • Published on 07/07/2026 at 18:10, 14 hours 41 minutes ago

    LNA Santé and Euryale join forces to expand hospitalisation at home services across healthcare regions

  • Published on 07/07/2026 at 18:05, 14 hours 46 minutes ago

    Covivio - Half-yearly report on the liquidity contract on 30 June 2026

  • Published on 07/07/2026 at 18:01, 14 hours 50 minutes ago

    Covivio - Information on total number of voting rights and share capital

  • Published on 07/07/2026 at 18:00, 14 hours 51 minutes ago

    Share Buyback Offer (OPRA) favored to implement shareholder return following the sale of Novacel

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy